MON-382 Bone Quality and Strength in Obese Men with Type 2 Diabetes Mellitus Are Impaired and Negatively Influenced by Adiposity

por Vigevano, Francesca, Chen, Rui, Colleluori, Georgia, Auetumrongsawat, Vimlin, Gregori, Giulia, Villareal, Dennis, Armamento-Villareal, Reina
Publicado 2020

MON-094 Aromatase Inhibitors and Weight Loss in Severely Obese Male Veterans with Hypogonadism: A Randomized Clinical Trial

por Colleluori, Georgia, Chen, Rui, Turin, Christie, Vigevano, Francesca, Qualls, Clifford, Mediwala, Sanjay, Villareal, Dennis, Armamento-Villareal, Reina
Publicado 2019

SUN-LB69 A Comparison Between Weight Loss Associated Bone Loss From Lifestyle Measures Versus Bariatric Surgery

por La, Betty, Vigevano, Francesca, Chitrapu, Prathyusha V, Gupta, Anisha, Auetumrongsawat, Vimlin, Villareal, Dennis Tan, Armamento-Villareal, Reina Condevillamar
Publicado 2020

Aromatase Inhibitors Plus Weight Loss Improves the Hormonal Profile of Obese Hypogonadal Men Without Causing Major Side Effects

por Colleluori, Georgia, Chen, Rui, Turin, Christie G., Vigevano, Francesca, Qualls, Clifford, Johnson, Biju, Mediwala, Sanjay, Villareal, Dennis T., Armamento-Villareal, Reina
Publicado 2020

Hemoglobin A1c of 7% is the Threshold For Bone Impairment in Men With Type 2 Diabetes Mellitus

por Joad, Sabaa Salim, Gregori, Giulia, Russo, Vittoria, Aguirre, Lina E, Colleluori, Georgia, Chen, Rui, Vigevano, Francesca, Villareal, Dennis Tan, Qualls, Clifford, Villareal, Reina Condevillamar
Publicado 2021